Clinical and immunopathological features of Moyamoya disease

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Lin, Runhua ^a,c   Xie, Zeyu ^b   Zhang, Jianfa ^c   Xu, Hongwu ^b   Su, Hang ^a   Tan, Xuerui ^c   Tian, Dongping ^a   Su, Min ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G;

ADULT; AGE DISTRIBUTION; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTOPSY; BRAIN HEMORRHAGE; CELL MIGRATION; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; INFLAMMATORY INFILTRATE; MAJOR CLINICAL STUDY; MALE; MOYAMOYA DISEASE; ONSET AGE; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SEX RATIO; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ADOLESCENT; AGED; BLOOD VESSEL; CHILD; FOLLOW UP; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGED; AUTOPSY; BLOOD VESSELS; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOYAMOYA DISEASE; YOUNG ADULT;

EID: 84860476303     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036386     Document Type: Article

References (27)

1. Kuroda S, Houkin K, (2008) Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7: 1056-1066.
2. Suzuki J, Takaku A, (1969) Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20: 288-299.
3. Takeuchi K, Shimizu K, (1957) Hypoplasia of the bilateral internal carotid arteries. Brain Nerve 9: 37-43.
4. Burke GM, Burke AM, Sherma AK, Hurley MC, Batjer HH, et al. (2009) Moyamoya disease: a summary. Neurosurg Focus 26: E11.
5. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, et al. (2008) Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39: 42-47.
6. Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, et al. (2005) Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36: 2148-2153.
7. Reid AJ, Bhattacharjee MB, Regalado ES, Milewicz AL, El-Hakam LM, et al. (2010) Diffuse and uncontrolled vascular smooth muscle cell proliferation in rapidly progressing pediatric moyamoya disease. J Neurosurg Pediatr 6: 244-249.
8. Chiu D, Shedden P, Bratina P, Grotta JC, (1998) Clinical features of moyamoya disease in the United States. Stroke 29: 1347-1351.
9. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, et al. (1997) Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 99 (Suppl 2): S1-5.
10. Duan L, Bao XY, Yang WZ, Shi WC, Li DS, et al. (2012) Moyamoya disease in china: its clinical features and outcomes. Stroke 43: 56-60.
11. Battistella PA, Carollo C, (1997) Clinical and neuroradiological findings of moyamoya disease in Italy. Clin Neurol Neurosurg 99 (Suppl 2): S54-57.
12. Borota L, Bajic R, Marinkovic S, Maksimovic R, Markovic Z, et al. (1997) The main epidemiological, clinical and morphological features of moyamoya disease in Yugoslavia. Clin Neurol Neurosurg 99 (Suppl 2): S49-53.
13. Graham JF, Matoba A, (1997) A survey of moyamoya disease in Hawaii. Clin Neurol Neurosurg 99 (Suppl 2): S31-35.
14. Numaguchi Y, Gonzalez CF, Davis PC, Monajati A, Afshani E, et al. (1997) Moyamoya disease in the United States. Clin Neurol Neurosurg 99 (Suppl 2): S26-30.
15. Han DH, Kwon OK, Byun BJ, Choi BY, Choi CW, et al. (2000) A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien) 142: 1263-1273; discussion 1273-1264.
16. Kraemer M, Heienbrok W, Berlit P, (2008) Moyamoya disease in Europeans. Stroke 39: 3193-3200.
17. Miao W, Zhao PL, Zhang YS, Liu HY, Chang Y, et al. (2010) Epidemiological and clinical features of Moyamoya disease in Nanjing, China. Clin Neurol Neurosurg 112: 199-203.
18. Baba T, Houkin K, Kuroda S, (2008) Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79: 900-904.
19. Oka K, Yamashita M, Sadoshima S, Tanaka K, (1981) Cerebral haemorrhage in Moyamoya disease at autopsy. Virchows Arch A Pathol Anat Histol 392: 247-261.
20. Yamashita M, Oka K, Tanaka K, (1983) Histopathology of the brain vascular network in moyamoya disease. Stroke 14: 50-58.
21. Hosoda Y, Ikeda E, Hirose S, (1997) Histopathological studies on spontaneous occlusion of the circle of Willis (cerebrovascular moyamoya disease). Clin Neurol Neurosurg 99 (Suppl 2): S203-208.
22. Takekawa Y, Umezawa T, Ueno Y, Sawada T, Kobayashi M, (2004) Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease. Neuropathology 24: 236-242.
23. He Y, Zhou Q, He M, (2010) An asymptomatic Moyamoya disease: autopsy case and literature review. Am J Forensic Med Pathol 31: 77-79.
24. Mishra SK, Siddique HR, Saleem M, (2011) S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev.
25. Chen D, Zheng XF, Yang ZY, Liu DX, Zhang GY, et al. (2012) S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells. World J Gastroenterol 18: 915-922.
26. Grigorian M, Ambartsumian N, Lukanidin E, (2008) Metastasis-inducing S100A4 protein: implication in non-malignant human pathologies. Curr Mol Med 8: 492-496.
27. Brisset AC, Hao H, Camenzind E, Bacchetta M, Geinoz A, et al. (2007) Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro. Circ Res 100: 1055-1062.